I've been looking at this stock and wondering what the present...

I've been looking at this stock and wondering what the present sales are of this product. There was an ASX announcement in June which stated:

Influenzas and Swine flu – as one of the most effective natural lines of defence in avoiding any
influenza is a strong and healthy immune system, the Company’s Immunoxel immunomodulator
may prove to be highly effective in reducing the incidence of swine flu when taken during any
flu season or other period of exposure risk. Clinical data gathered over several years has
demonstrated that Immunoxel can be effective in warding off or treating seasonal influenza
infection. In the Ukraine where Immunoxel is sold over the counter in pharmacies it is estimated
that around 500,000 people use Immunoxel as a flu preventative or treatment annually.
Influenza epidemics, as seasonal flu, are a common global occurrence with around 3-5 million.

Is Stirling products the only company marketing Immunoxel or is it marketed by others? Also is it the only company marketing Provale animal supplements? If this is so I'm surprised the market cap. is so low especially considering the extent of the markets. Perhaps I have miscalculated but does anyone else calculate the market cap. as between $6 to $7 mill?